3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Interventional
1
Sponsor
Cancer Type
Lymphoid
1
Gynecologic
1
Conditions
Esophageal Neoplasms
3
Uterine Cervical Neoplasms
2
Esophageal Squamous Cell Carcinoma
2
Recurrence
1
Pathologic Complete Response
1
Lymphoma, Follicular
1
Lymphatic Metastasis
1
Glioma
1
Glioblastoma
1
Endometrial Neoplasms
1
Disease
1
Chemotherapy Induced Cardiotoxicity in Breast Cancer Patients
1
Brain Neoplasms
1
Adenocarcinoma Of Esophagus
1
Interventions
Surveys and Questionnaires
16
Blood Specimen Collection
7
Observation
5
Surgical Procedures, Operative
4
Interviews as Topic
4
Hysteroscopy
4
Hysterectomy
4
Ultrasonography
2
Specimen Handling
2
Sentinel Lymph Node Biopsy
2
Reverse Transcriptase Polymerase Chain Reaction
2
Psychiatric Rehabilitation
2
Magnetic Resonance Spectroscopy
2
Laparoscopy
2
Immunohistochemistry
2
High-Energy Shock Waves
2
Drug Therapy
2
Data Collection
2
Biopsy
2
Base Sequence
2
trastuzumab deruxtecan
1
sarcolipin
1
rubitecan
1
olaparib
1
dostarlimab
1
apixaban
1
X-Rays
1
Vaginal Smears
1
Tissue Banks
1
Therapeutics
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Observational
×
Endometrial Neoplasms
×
Diffusion Magnetic Resonance Imaging
×
Clear all
NCT01836484
2020-02-13
MAPPING
Barts & The London NHS Trust
Completed
162 enrolled